Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
Cancers evolve at a dynamic pace to adapt to immune pressure, colonize new niches, and evade therapy. Tracking these changes can help us improve diagnosis, better tailor therapies, and forestall recurrence, but it requires intensive monitoring beyond current clinical practice. The TRACERx project, set up in 2014, aims to integrate new technologies to study cancer evolution in up to 840 lung cancer patients. From analyzing longitudinal changes in tumor DNA, to studying how these changes can be detected in blood, and expanding into the characterization of tumor immune and tissue microenvironments, several groups work collaboratively to decipher patterns and mechanisms of evolution, with the aim of applying them to improve lung cancer care.
This collection showcases the work of the TRACERx consortium, and provides further resources to explore the data and analyses published up to date. Browse the most recent publications in Nature Research, previous work, as well as Comments and community-generated content.